<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695196116668</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>Research Analysts Offer Predictions for Novartis AG’s Q1 2017 Earnings (NVS)</TITLE>


<TEXT>
Novartis AG (NYSE:NVS) – Leerink Swann <EVENT eid="e1" class="OCCURRENCE">upped</EVENT> their Q1 <TIMEX3 tid="t1" type="DATE" value="2017">2017</TIMEX3> earnings per share (EPS) <EVENT eid="e2" class="I_STATE">estimates</EVENT> for shares of Novartis AG in a research report <EVENT eid="e3" class="OCCURRENCE">issued</EVENT> to clients and investors on <TIMEX3 tid="t2" type="DATE" value="2017-01-26">Thursday</TIMEX3>. Leerink Swann analyst S. Fernandez <TIMEX3 tid="t3" type="DATE" value="PRESENT_REF">now</TIMEX3> <EVENT eid="e4" class="I_STATE">anticipates</EVENT> that the brokerage will <EVENT eid="e5" class="OCCURRENCE">post</EVENT> earnings of $1.15 per share for <TIMEX3 tid="t4" type="DATE" value="2017-Q1">the quarter</TIMEX3>, up from their previous forecast of $1.14. Leerink Swann also <EVENT eid="e6" class="REPORTING">issued</EVENT> estimates for Novartis AG’s Q2 <TIMEX3 tid="t5" type="DATE" value="2017">2017</TIMEX3> earnings at $1.22 EPS, Q3 <TIMEX3 tid="t6" type="DATE" value="2017">2017</TIMEX3> earnings at $1.25 EPS, Q4 <TIMEX3 tid="t7" type="DATE" value="2017">2017</TIMEX3> earnings at $1.29 EPS and FY2021 earnings at $6.36 EPS. 

Several other research analysts also <TIMEX3 tid="t8" type="DATE" value="PAST_REF">recently</TIMEX3> <EVENT eid="e7" class="OCCURRENCE">commented</EVENT> on NVS. Chardan Capital <EVENT eid="e8" class="OCCURRENCE">reduced</EVENT> their price target on shares of Novartis AG from $95.00 to $92.00 and <EVENT eid="e9" class="OCCURRENCE">set</EVENT> a “<EVENT eid="e10" class="OCCURRENCE">buy</EVENT>” rating on the stock in a research note on <TIMEX3 tid="t9" type="DATE" value="2017-01-23">Monday</TIMEX3>, October <TIMEX3 tid="t10" type="DATE" value="X">10th</TIMEX3>. J P Morgan Chase  amp; Co <EVENT eid="e11" class="OCCURRENCE">reaffirmed</EVENT> a “<EVENT eid="e12" class="OCCURRENCE">buy</EVENT>” <EVENT eid="e13" class="OCCURRENCE">rating</EVENT> on shares of Novartis AG in a research note on <TIMEX3 tid="t11" type="DATE" value="2017-01-23">Monday</TIMEX3>, October <TIMEX3 tid="t12" type="DATE" value="X">10th</TIMEX3>. Jefferies Group LLC <EVENT eid="e14" class="OCCURRENCE">reaffirmed</EVENT> a “buy” <EVENT eid="e15" class="OCCURRENCE">rating</EVENT> on shares of Novartis AG in a research note on <TIMEX3 tid="t13" type="DATE" value="2017-01-29">Sunday</TIMEX3>, <TIMEX3 tid="t14" type="DATE" value="2017-10">October 16th</TIMEX3>. Societe Generale <EVENT eid="e16" class="OCCURRENCE">reissued</EVENT> a “hold” <EVENT eid="e17" class="OCCURRENCE">rating</EVENT> on shares of Novartis AG in a research report on <TIMEX3 tid="t15" type="DATE" value="2017-01-26">Thursday, October 27th</TIMEX3>. Finally, Argus <EVENT eid="e18" class="OCCURRENCE">raised</EVENT> shares of Novartis AG from a “hold” rating to a “buy” rating and <EVENT eid="e19" class="OCCURRENCE">set</EVENT> a $85.00 target price on the stock in a research report on <TIMEX3 tid="t16" type="DATE" value="2017-01-26">Thursday</TIMEX3>, <TIMEX3 tid="t17" type="DATE" value="2017-11">November 10th</TIMEX3>. Two equities research analysts have <EVENT eid="e20" class="OCCURRENCE">rated</EVENT> the stock with a sell rating, eleven have assigned a hold <EVENT eid="e21" class="OCCURRENCE">rating</EVENT> and three have <EVENT eid="e22" class="OCCURRENCE">issued</EVENT> a buy rating to the company. The stock has an average <EVENT eid="e23" class="STATE">rating</EVENT> of “Hold” and a consensus price target of $85.18.

ILLEGAL ACTIVITY WARNING: This piece of content was first <EVENT eid="e24" class="OCCURRENCE">published</EVENT> by sleekmoney and is the sole property of of sleekmoney. If you are <EVENT eid="e25" class="OCCURRENCE">reading</EVENT> this piece of content on another site, it was illegally <EVENT eid="e26" class="OCCURRENCE">copied</EVENT> and <EVENT eid="e27" class="OCCURRENCE">reposted</EVENT> in <EVENT eid="e28" class="OCCURRENCE">violation</EVENT> of United States and international copyright laws. The correct version of this piece of content can be <EVENT eid="e29" class="OCCURRENCE">accessed</EVENT> at http://sleekmoney.com/research analysts <EVENT eid="e30" class="OCCURRENCE">offer</EVENT> predictions for novartis ags q1 <TIMEX3 tid="t18" type="DATE" value="2017">2017</TIMEX3> earnings nvs/1630106.html. 

Novartis AG (NYSE:NVS) <EVENT eid="e31" class="OCCURRENCE">opened</EVENT> at 72.21 on <TIMEX3 tid="t19" type="DATE" value="2017-01-27">Friday</TIMEX3>. The stock’s <TIMEX3 tid="t20" type="DATE" value="X">50</TIMEX3> day moving average is $71.89 and its 200 day moving average is $76.07. Novartis AG has a <TIMEX3 tid="t21" type="DURATION" value="P12M">12 month</TIMEX3> low of $66.93 and a <TIMEX3 tid="t22" type="DURATION" value="P12M">12 month</TIMEX3> high of $83.58. The stock has a market capitalization of $171.50 billion, a PE ratio of 25.79 and a beta of 0.68. Novartis AG (NYSE:NVS) last <EVENT eid="e32" class="OCCURRENCE">issued</EVENT> its earnings results on <TIMEX3 tid="t23" type="DATE" value="2017-01-25">Wednesday, January 25th</TIMEX3>. The company <EVENT eid="e33" class="OCCURRENCE">reported</EVENT> $1.12 earnings per share (EPS) for <TIMEX3 tid="t24" type="DATE" value="2017-Q1">the quarter</TIMEX3>, <EVENT eid="e34" class="OCCURRENCE">hitting</EVENT> the consensus estimate of $1.12. Novartis AG <EVENT eid="e35" class="OCCURRENCE">had</EVENT> a net margin of 13.80% and a return on equity of 15.46%. The firm <EVENT eid="e36" class="STATE">had</EVENT> revenue of $12.32 billion for <TIMEX3 tid="t25" type="DATE" value="2017-Q1">the quarter</TIMEX3>, compared to the consensus estimate of $12.44 billion. During <TIMEX3 tid="t26" type="DATE" value="2017-Q1">the same quarter</TIMEX3> in <TIMEX3 tid="t27" type="DURATION" value="PXY">the prior year</TIMEX3>, the firm <EVENT eid="e37" class="OCCURRENCE">posted</EVENT> $1.14 earnings per share. The business’s revenue was down 1.6% on <TIMEX3 tid="t28" type="DURATION" value="P1Y">a year over year</TIMEX3> basis. 

ILLEGAL ACTIVITY WARNING: This piece of content was first <EVENT eid="e38" class="OCCURRENCE">published</EVENT> by sleekmoney and is the sole property of of sleekmoney. If you are <EVENT eid="e39" class="OCCURRENCE">reading</EVENT> this piece of content on another site, it was illegally <EVENT eid="e40" class="OCCURRENCE">copied</EVENT> and <EVENT eid="e41" class="OCCURRENCE">reposted</EVENT> in violation of United States and international copyright laws. The correct version of this piece of content can be <EVENT eid="e42" class="OCCURRENCE">accessed</EVENT> at http://sleekmoney.com/research analysts <EVENT eid="e43" class="OCCURRENCE">offer</EVENT> predictions for novartis ags q1 <TIMEX3 tid="t29" type="DATE" value="2017">2017</TIMEX3> earnings nvs/1630106.html. 

A number of hedge funds have recently <EVENT eid="e44" class="OCCURRENCE">added</EVENT> to or <EVENT eid="e45" class="OCCURRENCE">reduced</EVENT> their stakes in the company. WFG Advisors LP <EVENT eid="e46" class="OCCURRENCE">boosted</EVENT> its stake in Novartis AG by 8.9% in <TIMEX3 tid="t30" type="DATE" value="2017-Q2">the second quarter</TIMEX3>. WFG Advisors LP <TIMEX3 tid="t31" type="DATE" value="PRESENT_REF">now</TIMEX3> <EVENT eid="e47" class="STATE">owns</EVENT> 1,624 shares of the company’s stock worth $134,000 after <EVENT eid="e48" class="OCCURRENCE">buying</EVENT> an additional 133 shares during the period. Mosaic Family Wealth LLC <EVENT eid="e49" class="OCCURRENCE">boosted</EVENT> its stake in Novartis AG by 11.2% in <TIMEX3 tid="t32" type="DATE" value="2017-Q3">the third quarter</TIMEX3>. Mosaic Family Wealth LLC <TIMEX3 tid="t33" type="DATE" value="PRESENT_REF">now</TIMEX3> <EVENT eid="e50" class="STATE">owns</EVENT> 1,886 shares of the company’s stock worth $149,000 after <EVENT eid="e51" class="OCCURRENCE">buying</EVENT> an additional 190 shares during the period. First PREMIER Bank <EVENT eid="e52" class="OCCURRENCE">boosted</EVENT> its stake in Novartis AG by 65.7% in <TIMEX3 tid="t34" type="DATE" value="2017-Q3">the third quarter</TIMEX3>. First PREMIER Bank <TIMEX3 tid="t35" type="DATE" value="PRESENT_REF">now</TIMEX3> <EVENT eid="e53" class="STATE">owns</EVENT> 1,955 shares of the company’s stock worth $154,000 after <EVENT eid="e54" class="OCCURRENCE">buying</EVENT> an additional 775 shares during the period. Integrated Wealth Counsel LLC <EVENT eid="e55" class="OCCURRENCE">boosted</EVENT> its stake in Novartis AG by 13.8% in <TIMEX3 tid="t36" type="DATE" value="2017-Q3">the third quarter</TIMEX3>. Integrated Wealth Counsel LLC <TIMEX3 tid="t37" type="DATE" value="PRESENT_REF">now</TIMEX3> <EVENT eid="e56" class="STATE">owns</EVENT> 1,998 shares of the company’s stock worth $158,000 after <EVENT eid="e57" class="OCCURRENCE">buying</EVENT> an additional 242 shares during the period. Finally, Chicago Partners Investment Group LLC <EVENT eid="e58" class="OCCURRENCE">bought</EVENT> a new stake in Novartis AG during <TIMEX3 tid="t38" type="DATE" value="2017-Q3">the third quarter</TIMEX3> worth approximately $158,000. Institutional investors own 9.84% of the company’s stock. 

Novartis AG Company Profile

Novartis AG is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products <EVENT eid="e59" class="OCCURRENCE">led</EVENT> by pharmaceuticals, including eye care products. Its portfolio includes medicines, eye care and generic pharmaceuticals. The Company’s segments include Pharmaceuticals, Alcon and Sandoz.
</TEXT>


<MAKEINSTANCE eiid="ie19" eventID="e19" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie59" eventID="e59" pos="VERB" tense="PASTPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie58" eventID="e58" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie55" eventID="e55" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie54" eventID="e54" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie57" eventID="e57" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie56" eventID="e56" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie51" eventID="e51" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie50" eventID="e50" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie53" eventID="e53" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie52" eventID="e52" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie42" eventID="e42" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie43" eventID="e43" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie40" eventID="e40" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie41" eventID="e41" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie46" eventID="e46" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie47" eventID="e47" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie44" eventID="e44" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie45" eventID="e45" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie48" eventID="e48" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie49" eventID="e49" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie37" eventID="e37" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie36" eventID="e36" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie35" eventID="e35" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie34" eventID="e34" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie33" eventID="e33" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie32" eventID="e32" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie31" eventID="e31" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie30" eventID="e30" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie39" eventID="e39" pos="VERB" tense="PRESENT" aspect="PROGRESSIVE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie38" eventID="e38" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie24" eventID="e24" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie25" eventID="e25" pos="VERB" tense="PRESENT" aspect="PROGRESSIVE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie26" eventID="e26" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie27" eventID="e27" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie22" eventID="e22" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie23" eventID="e23" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie28" eventID="e28" pos="NOUN" tense="NONE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie29" eventID="e29" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />

<TLINK lid="TL3" eventInstanceID="ie56" relatedToTime="t37" relType="IS_INCLUDED" />
<TLINK lid="TL2" eventInstanceID="ie58" relatedToTime="t38" relType="DURING" />
<TLINK lid="TL1" eventInstanceID="ie7" relatedToTime="t8" relType="IS_INCLUDED" />
<TLINK lid="TL0" eventInstanceID="ie4" relatedToTime="t3" relType="IS_INCLUDED" />
<TLINK lid="TL7" eventInstanceID="ie32" relatedToTime="t23" relType="IS_INCLUDED" />
<TLINK lid="TL6" eventInstanceID="ie47" relatedToTime="t31" relType="IS_INCLUDED" />
<TLINK lid="TL5" eventInstanceID="ie53" relatedToTime="t35" relType="IS_INCLUDED" />
<TLINK lid="TL4" eventInstanceID="ie50" relatedToTime="t33" relType="IS_INCLUDED" />
<TLINK lid="TL9" timeID="t35" relatedToEventInstance="ie53" relType="INCLUDES" />
<TLINK lid="TL8" eventInstanceID="ie31" relatedToTime="t19" relType="IS_INCLUDED" />
<TLINK lid="TL16" timeID="t31" relatedToEventInstance="ie47" relType="INCLUDES" />
<TLINK lid="TL15" timeID="t33" relatedToEventInstance="ie50" relType="INCLUDES" />
<TLINK lid="TL14" timeID="t37" relatedToEventInstance="ie56" relType="INCLUDES" />
<TLINK lid="TL13" timeID="t19" relatedToEventInstance="ie31" relType="INCLUDES" />
<TLINK lid="TL12" timeID="t16" relatedToTime="t17" relType="INCLUDES" />
<TLINK lid="TL11" timeID="t3" relatedToEventInstance="ie4" relType="INCLUDES" />
<TLINK lid="TL10" timeID="t8" relatedToEventInstance="ie7" relType="SIMULTANEOUS" />
</TimeML>
